ARTICLE | Company News
SkyePharma, Kowa Company Ltd. deal
February 20, 2001 8:00 AM UTC
SKP will provide materials for the scale-up and manufacturing for clinical trials of Kowa’s NK-104 lipid-lowering agent to treat high cholesterol (see BioCentury, Feb. 12). The compound is awaiting m...